MEDecision is Just the Latest Payer-Provided PHRs


By Neil Versel

July 8, 2008 | The pending acquisition of collaborative care management services vendor MEDecision by health insurer Health Care Service Corp. (HCSC) highlights a growing interest among payers in mining their vast data warehouses to create personal health records (PHRs) for their enrollees.

As has been widely reported, HCSC, the Chicago-based parent company of Blue Cross and Blue Shield of IllinoisBlue Cross and Blue Shield of New MexicoBlue Cross and Blue Shield of Oklahoma, and Blue Cross and Blue Shield of Texas, agreed last month to pay approximately $121 million in cash for MEDecision (Wayne, Pa.).

MEDecision, a developer of care management software, builds “patient clinical summaries” on behalf of health plans. The company says the records are clinically validated composites of patient data, “created by gathering clinical patient data from a variety of sources, cleaning and analyzing the data, and applying evidence-based medicine to present treatment opportunities, strategies, and plans for the provider and patient.

The idea of payer-based medical records is not new. The Boston-based Medical Records Institute says payers have been building rudimentary EMRs from claims for more than a decade. But there appears to be a growing trend of payers buying the health IT companies that produce such records.

The HCSC-MEDecision announcement follows on the heels of the April purchase of Columbia, Md.-based disease management software and data-analytics company Resolution Health by WellPoint, the nation’s largest commercial health insurer. Aetna has owned a similar firm, ActiveHealth, since 2005

UnitedHealth Group, through its Ingenix subsidiary, owns Integrated Healthcare Information Services (IHCIS), which offers predictive modeling and clinical decision support to health plans, employers, and providers. Another major private payer, Cigna, has a partnership with WebMD to provide PHRs to members.

South Carolina Medicaid reportedly is putting records of its beneficiaries online, following the lead of several other states, notably Tennessee. The latter is partnering with Cerner and Shared Health, a health IT subsidiary of BlueCross BlueShield of Tennessee.

Like many of its competitors, HCSC plans leaving MEDecision’s management structure largely intact, as an independently managed subsidiary. “This is going to be run as a standalone company,” says William Gerardi, HCSC executive director of clinical programs, policy, and technology.

HCSC, the largest not-for-profit Blues licensee, has been a MEDecision customer since 1994, according to MEDecision chairman and chief executive David St. Clair, and now accounts for 25 percent of his company’s revenue.

St. Clair founded MEDecision in 1988, and has always concentrated on aggregating data for dominant regional payers, which often means Blues plans. Other key customers for MEDecision, which went public in December 2006, include Medicaid managed care plans.

St. Clair says MEDecision is central to HCSC’s strategy of delivering better information to members and the physicians who care for them, which is why the Blues organization initiated the takeover talks. “We were approached by HCSC, so this is not something that we initiated,” St. Clair says. He has, however, publicly referred to HCSC as a “forward-thinking organization.”

Seeds of the deal were hatched when Patricia Hemingway Hall shifted from president of Blue Cross and Blue Shield of Texas to executive vice president for internal operations at the parent organization in December 2005. Hall, a nurse, rose through the ranks as part of the care management team, and, according to St. Clair, wanted to improve collaboration between HCSC’s regions. She was promoted to president and chief operating officer in November 2007.

Two weeks later, St. Clair says Hall called him to discuss an acquisition.

“We believe this is a strategic investment to us to help those who treat our members improve the quality of care,” Gerardi says. The HCSC clinical technology boss says the acquisition would provide the insurer with additional integration opportunities, perhaps with real-time claims adjudication.

Gerardi says it is too early to know more details, as the companies do not expect the deal to close until the end of the third quarter.

St. Clair says it is incorrect to view PHRs as the central piece of health information exchange, at least right now. “For us, a PHR today is a very small part of the puzzle,” he says. A better idea, according to St. Clair, is to engage clinicians in the use of pertinent data.

“I don’t think a broad play in the consumer area is going to make a huge difference in the cost of care in the near future,” St. Clair says. He believes it will take at least five years before that happens. “We don’t think the technology has been invented yet that will truly engage consumers.”

St. Clair says he met with several consumer-focused PHR vendors prior to the announcements that Microsoft and Google would offer platforms for aggregating personal health data, and determined that perhaps 0.1 percent of the U.S. population, or only about 300,000 people, had active, up-to-date electronic PHRs.

Until someone solves the adoption dilemma, payer-side PHRs likely will remain long-term strategies.

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.